• Product nameAnti-SUR1 antibody
    See all SUR1 primary antibodies
  • Description
    Goat polyclonal to SUR1
  • Tested applicationsSuitable for: WB, ELISAmore details
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Mouse, Rat, Guinea pig, Dog
  • Immunogen

    Synthetic peptide:


    (Human) from the C terminal of the protein sequence according to NP_000343.2.

  • Positive control
    • Human brain (cerebellum) lysates



Our Abpromise guarantee covers the use of ab77478 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
  • Application notesPeptide ELISA: Antibody detection limit dilution 1/8000.
    WB: Use at a concentration of 0.5 - 1.5 µg/ml. Detects a band of approximately 23 and 170 kDa (predicted molecular weight: 177 kDa). The 23 kDa band was successfully blocked by incubation with the immunising peptide.

    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • FunctionPutative subunit of the beta-cell ATP-sensitive potassium channel (KATP). Regulator of ATP-sensitive K(+) channels and insulin release.
    • Involvement in diseaseDefects in ABCC8 are a cause of leucine-induced hypoglycemia (LIH) [MIM:240800]; also known as leucine-sensitive hypoglycemia of infancy. LIH is a rare cause of hypoglycemia and is described as a condition in which symptomatic hypoglycemia is provoked by high protein feedings. Hypoglycemia is also elicited by administration of oral or intravenous infusions of a single amino acid, leucine.
      Defects in ABCC8 are the cause of familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450]; also known as persistent hyperinsulinemic hypoglycemia of infancy (PHHI) or congenital hyperinsulinism. HHF is the most common cause of persistent hypoglycemia in infancy and is due to defective negative feedback regulation of insulin secretion by low glucose levels. It causes nesidioblastosis, a diffuse abnormality of the pancreas in which there is extensive, often disorganized formation of new islets. Unless early and aggressive intervention is undertaken, brain damage from recurrent episodes of hypoglycemia may occur.
      Defects in ABCC8 are a cause of diabetes mellitus permanent neonatal (PNDM) [MIM:606176]. PNDM is a rare form of diabetes distinct from childhood-onset autoimmune diabetes mellitus type 1. It is characterized by insulin-requiring hyperglycemia that is diagnosed within the first months of life. Permanent neonatal diabetes requires lifelong therapy.
      Defects in ABCC8 are the cause of transient neonatal diabetes mellitus type 2 (TNDM2) [MIM:610374]. Neonatal diabetes is a form of diabetes mellitus defined by the onset of mild-to-severe hyperglycemia within the first months of life. Transient neonatal diabetes remits early, with a possible relapse during adolescence.
    • Sequence similaritiesBelongs to the ABC transporter superfamily. ABCC family. Conjugate transporter (TC 3.A.1.208) subfamily.
      Contains 2 ABC transmembrane type-1 domains.
      Contains 2 ABC transporter domains.
    • Cellular localizationMembrane.
    • Information by UniProt
    • Database links
    • Alternative names
      • ABC36 antibody
      • Abcc8 antibody
      • ABCC8_HUMAN antibody
      • ATP binding cassette sub family C (CFTR/MRP) member 8 antibody
      • ATP binding cassette transporter sub family C member 8 (1) antibody
      • ATP-binding cassette sub-family C member 8 antibody
      • HHF1 antibody
      • HI antibody
      • HRINS antibody
      • MRP8 antibody
      • PHHI antibody
      • Sulfonylurea receptor (hyperinsulinemia) antibody
      • Sulfonylurea receptor 1 antibody
      • SUR antibody
      • SUR1 antibody
      • SUR1delta2 antibody
      • TNDM2 antibody
      see all

    Anti-SUR1 antibody images

    • Anti-SUR1 antibody (ab77478) at 0.5 µg/ml + human cerebellum lysate in RIPA buffer at 35 µg

      Predicted band size : 177 kDa
      Observed band size : 170 kDa (why is the actual band size different from the predicted?)
      Additional bands at : 23 kDa. We are unsure as to the identity of these extra bands.

    References for Anti-SUR1 antibody (ab77478)

    ab77478 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab77478.
    Please use the links above to contact us or submit feedback about this product.